相关实验视频

Updated: Jun 29, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

天然化合物向质瘤干细胞

Mariia Yaroshenko¹, Monika Christoff¹, Mateusz Ścibiorski²

¹Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland.

|June 25, 2025

概括

结质瘤,侵略性脑瘤,由于结质瘤干细胞 (GSCs) 具有挑战性,因此难以治疗. 自然化合物提供了一个有前途的治疗策略,针对这些GSC,以改善结果.

科学领域:

神经瘤学神经瘤学
癌症生物学癌症生物学
药理学药理学是指药理学的学科.

背景情况:

质瘤是最常见的中枢神经系统瘤,占初级脑瘤的30%,恶性瘤的80%.
多形质母细胞瘤特别具有攻击性,其异质性和质母细胞 (GSCs) 的存在使治疗复杂化.
放射治疗和化疗等传统疗法对质瘤的疗效有限,这凸显了对新型治疗方法的需求.

研究的目的:

在质瘤治疗的背景下,审查与质瘤干细胞 (GSCs) 相关的挑战.
探索目前用于质瘤的治疗策略,强调其局限性.
突出天然化合物的潜力,作为未来质瘤治疗中GSC的向治疗.

主要方法:

关于质瘤流行病学和治疗的文献评论.
分析质瘤干细胞 (GSCs) 在瘤进展和治疗耐药性方面的作用.
探索具有潜在抗GSC活性的天然化合物.

主要成果:

质瘤干细胞 (GSCs) 被认为是质瘤对传统疗法的耐药性的一个关键因素.
目前用于质瘤的治疗方法,包括放射治疗和化疗,往往无法根除GSC,导致瘤复发.
天然化合物在向和消除GSC方面表现出潜力,这表明了新疗法开发的有前途途途.

结论:

质瘤干细胞 (GSCs) 在治疗质瘤方面具有重大治疗挑战.
向GSC对于改善质瘤患者治疗结果至关重要.
天然化合物代表了未来质瘤治疗的有希望和可行的策略,特别是针对GSCs.

关键词:

质母细胞瘤 (glioblastoma) 是一种细胞质瘤干细胞质瘤治疗质瘤治疗自然化合物自然化合物

更多相关视频

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.